10-72005899-G-GATGAGAAGCAAATACGCCCT
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate
The NM_004273.5(CHST3):c.58_77dupATGAGAAGCAAATACGCCCT(p.Phe27fs) variant causes a frameshift, stop gained change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Genomes: not found (cov: 33)
Consequence
CHST3
NM_004273.5 frameshift, stop_gained
NM_004273.5 frameshift, stop_gained
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 8.70
Genes affected
CHST3 (HGNC:1971): (carbohydrate sulfotransferase 3) This gene encodes an enzyme which catalyzes the sulfation of chondroitin, a proteoglycan found in the extracellular matrix and most cells which is involved in cell migration and differentiation. Mutations in this gene are associated with spondylepiphyseal dysplasia and humerospinal dysostosis. [provided by RefSeq, Mar 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most 50 bp of the penultimate exon, not predicted to undergo nonsense mediated mRNA decay. There are 4 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 10-72005899-G-GATGAGAAGCAAATACGCCCT is Pathogenic according to our data. Variant chr10-72005899-G-GATGAGAAGCAAATACGCCCT is described in ClinVar as [Pathogenic]. Clinvar id is 1996399.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHST3 | NM_004273.5 | c.58_77dupATGAGAAGCAAATACGCCCT | p.Phe27fs | frameshift_variant, stop_gained | 2/3 | ENST00000373115.5 | NP_004264.2 | |
CHST3 | XM_006718075.5 | c.58_77dupATGAGAAGCAAATACGCCCT | p.Phe27fs | frameshift_variant, stop_gained | 2/3 | XP_006718138.1 | ||
CHST3 | XM_011540369.3 | c.58_77dupATGAGAAGCAAATACGCCCT | p.Phe27fs | frameshift_variant, stop_gained | 2/3 | XP_011538671.1 | ||
CHST3 | XM_047426022.1 | c.58_77dupATGAGAAGCAAATACGCCCT | p.Phe27fs | frameshift_variant, stop_gained | 2/3 | XP_047281978.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHST3 | ENST00000373115.5 | c.58_77dupATGAGAAGCAAATACGCCCT | p.Phe27fs | frameshift_variant, stop_gained | 2/3 | 1 | NM_004273.5 | ENSP00000362207.4 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD4 exome Cov.: 32
GnomAD4 exome
Cov.:
32
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
Bravo
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Spondyloepiphyseal dysplasia with congenital joint dislocations Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 19, 2022 | This sequence change creates a premature translational stop signal (p.Phe27*) in the CHST3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CHST3 are known to be pathogenic (PMID: 18513679, 20830804, 24300290). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with CHST3-related conditions. For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at